Literature DB >> 17218555

A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD.

Fanny W S Ko1, Margaret Ip, Paul K S Chan, Joan P C Fok, Michael C H Chan, Jenny C Ngai, Doris P S Chan, David S C Hui.   

Abstract

INTRODUCTION: Infection is a major cause of acute exacerbations of COPD (AECOPDs). We aimed to study the infectious etiology related to AECOPD.
METHODS: Patients admitted to an acute care hospital in Hong Kong with an AECOPD were recruited prospectively from May 1, 2004, to April 30, 2005. Sputum samples, nasopharyngeal aspirate (NPA) samples, and paired serology specimens were collected. Spirometry was performed with patients in the stable phase 2 to 3 months after hospital discharge.
RESULTS: There were 643 episodes of AECOPD among 373 patients. Their mean age was 75.3 years (SD, 7.9 years) with 307 male patients. The mean FEV(1) was 40.4% predicted (SD, 18.7% predicted), and the mean FEV(1)/FVC ratio was 58.4% (SD, 16.0%). Among sputum samples from the 530 episodes of AECOPD hospital admissions that were saved, 13.0%, 6.0%, and 5.5%, respectively, had positive growth of Haemophilus influenzae, Pseudomonas aeruginosa, and Streptococcus pneumoniae. Among the 505 hospital admissions with patients who had NPA samples saved, 5.7%, 2.3%, 0.8%, and 0.8%, respectively, had influenza A, respiratory syncytial virus (RSV), influenza B, and parainfluenza 3 isolated from viral cultures. Paired serology test results revealed a fourfold rise in viral titers in 5.2%, 2.2%, and 1.4% of patients, respectively, for influenza A, RSV, and influenza B. Very severe airflow obstruction (stable-state spirometry) was associated with a higher chance of a positive sputum culture (FEV(1) >/= 30% predicted, 28.2%; FEV(1) < 30% predicted, 40.4%; p = 0.006).
CONCLUSION: H influenzae and influenza A were the most common etiologic agents in patients who were hospitalized with AECOPDs. More severe airflow obstruction was associated with a higher chance of a positive sputum culture finding.

Entities:  

Mesh:

Year:  2007        PMID: 17218555     DOI: 10.1378/chest.06-1355

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

1.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.

Authors:  Ashok Kuwal; Vinod Joshi; Naveen Dutt; Surjit Singh; Kailash Chand Agarwal; Gopal Purohit
Journal:  Turk Thorac J       Date:  2017-11-29

Review 4.  Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.

Authors:  Chun Geun Lee; Bing Ma; Seyedtaghi Takyar; Farida Ahangari; Charles Delacruz; Chuan Hua He; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2011-11

Review 5.  The ABCs of rhinoviruses, wheezing, and asthma.

Authors:  James E Gern
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

6.  Sputum mucin 1 is increased during the acute phase of chronic obstructive pulmonary disease exacerbation.

Authors:  Zeguang Zheng; Yafei Qi; Xiaoming Xu; Hua Jiang; Zhengtu Li; Quan Yang; Chenting Zhang; Kedong Zhang; Rongchang Chen; Jian Wang; Wenju Lu
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 7.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study.

Authors:  M Montero; M Domínguez; M Orozco-Levi; M Salvadó; H Knobel
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

9.  Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.

Authors:  Min-Jong Kang; Chun Geun Lee; Jae-Young Lee; Charles S Dela Cruz; Zhijian J Chen; Richard Enelow; Jack A Elias
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.

Authors:  Allison L Miller; Gary P Sims; Yambasu A Brewah; Marlon C Rebelatto; Jennifer Kearley; Ebony Benjamin; Ashley E Keller; Philip Brohawn; Ronald Herbst; Anthony J Coyle; Alison A Humbles; Roland Kolbeck
Journal:  J Infect Dis       Date:  2012-01-18       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.